capecitabine has been researched along with chitosan in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Agnihotri, SA; Aminabhavi, TM | 1 |
| Ganesh, M; Jang, HT; Rathnam, G; Sinha, P; Udhumansha, U | 1 |
| Agrawal, RK; Iyer, AK; Jain, S; Kashaw, SK; Kushwah, V; Sahu, P; Sau, S | 1 |
| Karimian, H; Mokhtari, A; Niazi Saei, J | 1 |
| Ganesh, GNK; Pindiprolu, SKSS; Sanapalli, BKR; Singh, MK; Yele, V | 1 |
| Cheruku, SP; Day, CM; Gadag, S; Garg, S; Kumar, N; Manandhar, S; Mehta, CH; Narayan, R; Nayak, UY; Nayak, Y; Pai, KSR; Raichur, AM; Suresh, A | 1 |
| Alanazi, IM; Alzahrani, AR; Arulselvan, P; Azlina, MFN; Falemban, AH; Ibrahim, IAA; Shahid, I; Shahzad, N | 1 |
1 review(s) available for capecitabine and chitosan
| Article | Year |
|---|---|
Carbohydrate polymers-based surface modified nano delivery systems for enhanced target delivery to colon cancer - A review.
Topics: Capecitabine; Chitosan; Colonic Neoplasms; Delayed-Action Preparations; Humans; Nanoparticle Drug Delivery System; Polymers | 2023 |
6 other study(ies) available for capecitabine and chitosan
| Article | Year |
|---|---|
Novel interpenetrating network chitosan-poly(ethylene oxide-g-acrylamide) hydrogel microspheres for the controlled release of capecitabine.
Topics: Acrylic Resins; Calorimetry, Differential Scanning; Capecitabine; Chitosan; Delayed-Action Preparations; Deoxycytidine; Diffusion; Fluorouracil; Hydrogel, Polyethylene Glycol Dimethacrylate; Microspheres; Polyethylene Glycols; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2006 |
Capecitabine encapsulated chitosan succinate-sodium alginate macromolecular complex beads for colon cancer targeted delivery: in vitro evaluation.
Topics: Alginates; Animals; Capecitabine; Capsules; Cecum; Cell Survival; Chitosan; Colonic Neoplasms; Drug Carriers; Drug Liberation; Glucuronic Acid; Hexuronic Acids; HT29 Cells; Humans; Hydrogen-Ion Concentration; Kinetics; Rats; Temperature | 2018 |
pH triggered and charge attracted nanogel for simultaneous evaluation of penetration and toxicity against skin cancer: In-vitro and ex-vivo study.
Topics: Antineoplastic Agents; Apoptosis; Capecitabine; Cell Line; Chitosan; Diffusion; Drug Carriers; Drug Liberation; Ethylene Glycols; Gels; Humans; Hydrogen-Ion Concentration; Nanostructures; Particle Size; Permeability; Poloxamer; Skin; Skin Neoplasms; Surface Properties | 2019 |
Stopped-flow chemiluminescence determination of the anticancer drug capecitabine: Application in pharmaceutical analysis and drug-delivery systems.
Topics: Antineoplastic Agents; Capecitabine; Chitosan; Drug Delivery Systems; Flow Injection Analysis; Humans; Luminescent Measurements; Magnetite Nanoparticles; Molecular Structure; Particle Size; Potassium Permanganate; Surface Properties | 2020 |
HER2 targeted biological macromolecule modified liposomes for improved efficacy of capecitabine in breast cancer.
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Cell Line, Tumor; Chitosan; Female; Humans; Liposomes; Peptides; Receptor, ErbB-2 | 2020 |
Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy.
Topics: Animals; Capecitabine; Cell Line, Tumor; Cell Survival; Chitosan; Coated Materials, Biocompatible; Colorectal Neoplasms; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Glucuronic Acid; HCT116 Cells; Humans; Hydrogen-Ion Concentration; Nanoparticles; Particle Size; Porosity; Rats; Rats, Wistar; Silicon Dioxide; Xenograft Model Antitumor Assays | 2021 |